Dr. Reyhaneh nassiri mansour | regenerative medicine | Women Researcher Award
post doc, immunogenetic institue, Iran
Profile
Short Bio ๐ฑ
Reyhaneh Nassiri Mansour, born on June 5, 1986, in Tehran, Iran, is a clinical biochemist with a strong academic background and hands-on experience in stem cell research. With a focus on cancer research and regenerative medicine, she has contributed to significant advancements in biotechnology, particularly in the differentiation of stem cells into insulin-producing cells. Reyhaneh is an educator and researcher passionate about the interface of clinical biochemistry and molecular biology. She has published several peer-reviewed articles and presented her findings at international conferences.
Education ๐
Reyhaneh completed her B.Sc. in General Biology from Islamic Azad University, North Tehran Branch, in 2008. She further pursued an M.Sc. in Clinical Biochemistry at Zanjan University of Medical Sciences (2012-2015), where her thesis focused on the expression levels of HIF-1 alpha gene in colorectal cancer stages. Her academic work under the supervision of Dr. Mojtaba Fathi fueled her interest in gene expression and stem cell therapy.
Experience ๐งช
Reyhaneh has held multiple roles in academia and industry, contributing to her diverse skill set. She has worked as a research employee at Livogen Pharmed Co. and as a trainee at the Stem Cell Research Technology Center. With a deep understanding of laboratory techniques, including DNA extraction, real-time PCR, and stem cell culture, she has also taught General Biochemistry to B.Sc. students across various health disciplines at Zanjan University of Medical Sciences.
Research Interests ๐ฌ
Her research interests span stem cell therapy, gene expression, and cancer research. She has focused on developing insulin-producing cells from human-induced pluripotent stem cells (hiPSCs) and exploring the role of hypoxia-inducible factor-1 alpha in cancer. Reyhaneh is also invested in using tissue engineering and scaffolds for regenerative medicine.
Publications Top Notes ๐
- Evaluation of hypoxia-inducible factor-1 alpha gene expression in colorectal cancer stages of Iranian patients. Mansour RN, et al. J Cancer Res Ther. 2016; 12(4):1313-1317. DOI: 10.4103/0973-1482.199542 (Cited by 15 articles)
- Generation of high-yield insulin producing cells from human-induced pluripotent stem cells on polyethersulfone nanofibrous scaffold. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1434663 (Cited by 32 articles)
- Collagen-coated electrospun polyethersulfone nanofibers improved insulin-producing cells’ differentiation potential of human induced pluripotent stem cells. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1508031 (Cited by 25 articles)
- Improved stem cell therapy of spinal cord injury using GDNF-overexpressed bone marrow stem cells in a rat model. Shahrezaei M, Mansour RN, et al. Biologicals. 2017. DOI: 10.1016/j.Biologicals.2017.08.009 (Cited by 18 articles)
- Improved osteogenic differentiation of human induced pluripotent stem cells cultured on poly vinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Mansour RN, et al. J Cell Physiol. 2019. DOI: 10.1002/jcp.29029 (Cited by 20 articles)
- Generation of insulin-producing cells from human-induced pluripotent stem cells on PLLA/PVA nanofiber scaffold. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1443466 (Cited by 28 articles)
- In vitro osteogenic differentiation potential of human induced pluripotent stem cells augmented on graphene oxide-modified nanofibers. Mansour RN, et al. Gene. 2019. DOI: 10.1016/j.gene.2019.02.028 (Cited by 16 articles)
- Glioblastoma: Exosome and microRNA as novel diagnostic biomarkers. Mansour RN, et al. Cancer Gene Ther. 2016. DOI: 10.1038/cgt.2016.48 (Cited by 30 articles)